Independent
antitrust, consolidation, healthcare markets, healthcare prices, competition
drugs, price transparency, pharmaceuticals, state regulation, trade secrets, health policy
health care prices, all-payer claims database, insurance, price transparency, trade secrets, negotiated rates, competition, antitrust
healthcare markets, healthcare mergers, market consolidation, merger oversight, healthcare prices, competition. anti-trust